We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
+28.88%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$453M
AUM Growth
-$9.38M
(-2%)
Cap. Flow
-$94.9M
Cap. Flow
% of AUM
-20.93%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
909
New
156
Increased
102
Reduced
243
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.3M |
| 2 |
Microsoft
MSFT
|
+$6.19M |
| 3 |
Accenture
ACN
|
+$5.66M |
| 4 |
Biogen
BIIB
|
+$4.48M |
| 5 |
United Airlines
UAL
|
+$3.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$11.2M |
| 2 |
ExxonMobil
XOM
|
+$4.17M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$3.6M |
| 4 |
FedEx
FDX
|
+$3.15M |
| 5 |
Baidu
BIDU
|
+$2.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.06% |
| 2 | Consumer Discretionary | 12.14% |
| 3 | Healthcare | 10.09% |
| 4 | Consumer Staples | 9.74% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$780B
| $46.7M | 10.3% |
+151,500
| New | +$44.3M |
|
|
2
Microsoft
MSFT
$2.9T
| $6.94M | 1.53% |
+34,100
| New | +$6.19M |
|
|
3
Biogen
BIIB
$30B
| $6.69M | 1.48% |
25,000
+14,900
| +148% | +$4.48M |
|
|
4
Accenture
ACN
$94.4B
| $6.42M | 1.42% |
+29,900
| New | +$5.66M |
|
5
iShares Russell 2000 ETF
IWM
$79.9B
| $6.17M | 1.36% |
43,100
+22,300
| +107% | +$2.93M |
|
6
Target
TGT
$63.9B
| $5.14M | 1.13% |
42,900
+13,976
| +48% | +$1.6M |
|
7
Walmart Inc
WMT
$894B
| $4.85M | 1.07% |
121,428
+67,500
| +125% | +$2.78M |
|
8
DexCom
DXCM
$28.7B
| $4.65M | 1.03% |
45,880
-9,600
| -17% | -$859K |
|
9
Coca-Cola
KO
$361B
| $4.51M | 0.99% |
100,895
+29,900
| +42% | +$1.38M |
|
10
Walt Disney
DIS
$169B
| $4.08M | 0.9% |
36,600
+3,570
| +11% | +$394K |
|
11
Meta Platforms (Facebook)
META
$1.53T
| $3.89M | 0.86% |
17,119
+12,019
| +236% | +$2.51M |
|
12
Intel
INTC
$441B
| $3.81M | 0.84% |
63,600
+33,100
| +109% | +$1.98M |
|
|
13
United Airlines
UAL
$38.7B
| $3.79M | 0.84% |
+109,600
| New | +$3.29M |
|
14
Teladoc Health
TDOC
$1.59B
| $3.63M | 0.8% |
19,000
+6,800
| +56% | +$1.19M |
|
15
Lam Research
LRCX
$354B
| $3.62M | 0.8% |
112,000
+13,000
| +13% | +$355K |
|
16
Colgate-Palmolive
CL
$74.1B
| $3.58M | 0.79% |
48,800
+32,600
| +201% | +$2.32M |
|
17
Zillow
Z
$7.3B
| $3.3M | 0.73% |
57,292
-9,100
| -14% | -$452K |
|
18
TJX Companies
TJX
$173B
| $3.17M | 0.7% |
62,712
+24,500
| +64% | +$1.23M |
|
19
Monster Beverage
MNST
$93.5B
| $3.13M | 0.69% |
90,400
-25,200
| -22% | -$823K |
|
20
Qorvo
QRVO
$7.7B
| $2.9M | 0.64% |
26,200
-10,500
| -29% | -$1.04M |
|
21
Norwegian Cruise Line
NCLH
$9.12B
| $2.67M | 0.59% |
162,242
+112,805
| +228% | +$1.65M |
|
22
Charter Communications
CHTR
$15.1B
| $2.55M | 0.56% |
5,000
-2,600
| -34% | -$1.32M |
|
23
JD.com
JD
$41.1B
| $2.55M | 0.56% |
42,360
+22,760
| +116% | +$1.15M |
|
24
General Mills
GIS
$19.6B
| $2.47M | 0.54% |
40,000
+36,200
| +953% | +$2.18M |
|
|
GRMN
25
Garmin
GRMN
$46.7B
| $2.46M | 0.54% |
25,200
-11,600
| -32% | -$992K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Bayesian Capital Management held 909 positions worth $453M, down 2% from $463M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bayesian Capital Management withdrew a net $94.9M in Q2 2020, closing 406 positions and reducing 243 holdings. Its most notable exit was ExxonMobil, an estimated $4.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $46.7M.
- Bayesian Capital Management's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 151,500 shares worth $46.7M.
- Bayesian Capital Management added most to Biogen in Q2 2020, an estimated $4.48M increase.
- Bayesian Capital Management's biggest Q2 2020 reduction was Walgreens Boots Alliance, cutting an estimated $11.2M.
- Bayesian Capital Management fully exited ExxonMobil in Q2 2020, selling an estimated $4.17M.
- Bayesian Capital Management's ten largest holdings make up 21% of its $453M portfolio in Q2 2020.
- Bayesian Capital Management opened 156 new positions and closed 406 in Q2 2020.
- Bayesian Capital Management's portfolio value fell 2% quarter-over-quarter to $453M.
Based on Bayesian Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.